EUVIMEDEUVIMED entdecken
Crossref

Discovery of Darovasertib (NVP-LXS196), a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal Melanoma

Michael Visser iD, Julien P N Papillon iD, Michael Luzzio, Matthew J LaMarche iD, Jianmei Fan, Walter Michael, David Wang, Alan Zhang, Christopher Straub, Simon Mathieu, Mitsunori Kato, Mark Palermo und 15 weitere

Journal of Medicinal Chemistry · 25.01.2024 · 67 (2) · 1447-1459

DOI: 10.1021/acs.jmedchem.3c02002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 10.01.2024. Verfasst von Michael Visser und 26 weiteren Autor:innen. Beteiligte Einrichtung: Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States. Hauptthemen laut MEDLINE: Melanoma, Uveal Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaUveal NeoplasmsAdultHumansGTP-Binding Protein alpha SubunitsGTP-Binding Protein alpha Subunits, Gq-G11Protein Kinase InhibitorsMutationUveal Melanoma

Substanzen

GTP-Binding Protein alpha SubunitsGTP-Binding Protein alpha Subunits, Gq-G11Protein Kinase Inhibitors

Autor:innen und Institutionen

  • Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.

ORCID-Profile: Michael Visser, Julien P N Papillon, Matthew J LaMarche, Rosemary Barrett

Zitieren

APA

Visser, M., Papillon, J. P. N., Luzzio, M., LaMarche, M. J., Fan, J., Michael, W., Wang, D., Zhang, A., Straub, C., Mathieu, S., Kato, M., Palermo, M., Chen, C., Ramsey, T., Joud, C., Barrett, R., Vattay, A., Guo, R., Bric, A., …, & Cooke, V. G. (2024). Discovery of Darovasertib (NVP-LXS196), a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal Melanoma. Journal of Medicinal Chemistry, 67(2), 1447-1459. https://doi.org/10.1021/acs.jmedchem.3c02002

Vancouver

Visser M, Papillon JPN, Luzzio M, LaMarche MJ, Fan J, Michael W, et al. Discovery of Darovasertib (NVP-LXS196), a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal Melanoma. Journal of Medicinal Chemistry. 2024;67(2):1447-1459. doi:10.1021/acs.jmedchem.3c02002

BibTeX
@article{Visser2024,
  author = {Visser, Michael and Papillon, Julien P N and Luzzio, Michael and LaMarche, Matthew J and Fan, Jianmei and Michael, Walter and Wang, David and Zhang, Alan and Straub, Christopher and Mathieu, Simon and Kato, Mitsunori and Palermo, Mark and Chen, Christine and Ramsey, Timothy and Joud, Carol and Barrett, Rosemary and Vattay, Anthony and Guo, Ribo and Bric, Anka and Chung, Franklin and Liang, Guiqing and Romanowski, Michael J and Lam, Joni and Thohan, Sanjeev and Atassi, Faraj and Wylie, Andrew and Cooke, Vesselina G},
  title = {Discovery of Darovasertib (NVP-LXS196), a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal Melanoma},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  volume = {67},
  number = {2},
  pages = {1447--1459},
  doi = {10.1021/acs.jmedchem.3c02002}
}
Kostenlos starten →